Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome

J Viral Hepat. 2018 Feb;25(2):214-215. doi: 10.1111/jvh.12768. Epub 2017 Aug 30.

Authors

J von Felden¹, C Scheurich¹, J Yamamura², D M Brainard³, E Mogalian³, A W Lohse¹, J Schulze Zur Wiesch¹

Affiliations

¹ Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Department for Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
³ Gilead Sciences Inc, Foster City, CA, USA.

PMID: 28783205
DOI: 10.1111/jvh.12768

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Benzimidazoles
Crohn Disease
Fluorenes
Hepatitis C, Chronic*
Humans
Short Bowel Syndrome
Sofosbuvir*

Substances

Antiviral Agents
Benzimidazoles
Fluorenes
ledipasvir
Sofosbuvir